Swander Pace Capital Acquires Captek Softgel International

SAN FRANCISCO & NEW YORK--()--Swander Pace Capital, a leading private equity firm specializing in investments in consumer products companies, today announced it has completed the acquisition of California-based Captek Softgel International (“Captek”).

Captek, previously owned by Prairie Capital and Skyline Global Partners, is a leading manufacturer and distributor of softgels for vitamin, mineral and supplement (“VMS”) brands across all key sales channels to the North American and international markets. The company currently services more than 200 brands in 20 countries.

“Captek has established itself as a world-class manufacturer and marketer of specialized softgel products for domestic and international VMS brands,” said Corby Reese, a managing director at Swander Pace Capital. “We are extremely impressed with Captek’s management team and look forward to working with them to build upon Captek’s strong positioning and success.”

“I am extremely excited to announce this transaction and partnership with Swander Pace Capital,” said David Wood, CEO of Captek. “The firm has an incredible track record growing companies in the consumer products industry, and I look forward to partnering with them to enhance our market leadership as one of the top softgel companies in the world.”

“Captek is poised for significant growth with its high quality manufacturing, formulation expertise, and unparalleled customer service,” added Mark Poff, a managing director at Swander Pace Capital. “While the VMS category has strong growth, softgels are growing even faster due to their multiple end-use applications, high potency, and ease of swallowing, and we see Captek on the leading edge of that opportunity.”

Kirkland & Ellis LLP served as the legal advisor to Swander Pace Capital on the acquisition.

About Swander Pace Capital

Swander Pace Capital is a leading private equity firm specializing in investments in growth-oriented, middle-market consumer companies in North America and the United Kingdom. With cumulative equity commitments of approximately $1.3 billion, for the past 19 years Swander Pace Capital has used its expertise in this industry to pursue a consistent strategy of acquiring or investing in consumer products companies with leading market positions in attractive, defensible niches. Swander Pace Capital has led successful private equity investments in consumer companies with total revenues in excess of $2.0 billion. With staff in San Francisco, New Jersey, and Ontario (Toronto), Swander Pace Capital provides portfolio companies with a unique mix of financial, strategic, and tactical support to create long-term value. For more information, visit www.spcap.com.

About Captek Softgel International

Captek Softgel International, Inc. (CSI) is a privately-owned, FDA registered and audited, GMP-certified, full service contract manufacturer of custom dietary supplement formulations. CSI features high efficiency encapsulation lines operating 24/5, capable of producing over three billion softgels annually. The facility encompasses approximately 85,000 square feet of production, analytical laboratory, pilot laboratory, and warehousing space. Captek fully complies with FDA cGMPs and has been independently certified by NSF International. For more information, visit www.capteksoftgel.com.

Contacts

LANE (on behalf of Swander Pace Capital)
Amber Roberts, 212-302-5964
amber@lanepr.com

Release Summary

Swander Pace Capital, a leading private equity firm specializing in consumer products companies, today announced it has completed the acquisition of California-based Captek Softgel International.

Contacts

LANE (on behalf of Swander Pace Capital)
Amber Roberts, 212-302-5964
amber@lanepr.com